Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Becker

Showing results (151-160 of 283) with videos related to

Pageof 29
Sort By:
BJU International|May 9, 2013
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysisMarco Bianchi, Andreas Becker, Quoc-Dien Trinh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2012
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrenceKatharina Grupp, Sebastian Kohl, Hüseyin Sirma, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
Investigational New Drugs|July 6, 2023
Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substratesÖzkan Yalkinoglu, Andreas Becker, Axel Krebs-Brown, et al.
World Journal of Urology|May 14, 2014
A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral centerAndreas Becker, Daniel Seiler, Maciej Kwiatkowski, et al.
Urologia Internationalis|December 25, 2015
The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and GermanyChristian Meyer, Jens Hansen, Andreas Becker, et al.
Frontiers in Surgery|October 18, 2019
MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?Jessica Rührup, Felix Preisser, Lena Theißen, et al.
BMC Neuroscience|October 3, 2013
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegenerationAndreas Becker, Stephanie Kohlmann, Anca Alexandru, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 27, 2013
Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohortFlorian Roghmann, Andreas Becker, Quoc-Dien Trinh, et al.
European Urology Focus|July 13, 2019
Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior BiopsiesFelix Preisser, Lena Theissen, Mike Wenzel, et al.
Pageof 29

Showing results (151-160 of 283) with videos related to

Sort By:
Pageof 29
BJU International|May 9, 2013
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysisMarco Bianchi, Andreas Becker, Quoc-Dien Trinh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2012
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrenceKatharina Grupp, Sebastian Kohl, Hüseyin Sirma, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
Investigational New Drugs|July 6, 2023
Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substratesÖzkan Yalkinoglu, Andreas Becker, Axel Krebs-Brown, et al.
World Journal of Urology|May 14, 2014
A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral centerAndreas Becker, Daniel Seiler, Maciej Kwiatkowski, et al.
Urologia Internationalis|December 25, 2015
The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and GermanyChristian Meyer, Jens Hansen, Andreas Becker, et al.
Frontiers in Surgery|October 18, 2019
MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?Jessica Rührup, Felix Preisser, Lena Theißen, et al.
BMC Neuroscience|October 3, 2013
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegenerationAndreas Becker, Stephanie Kohlmann, Anca Alexandru, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 27, 2013
Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohortFlorian Roghmann, Andreas Becker, Quoc-Dien Trinh, et al.
European Urology Focus|July 13, 2019
Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior BiopsiesFelix Preisser, Lena Theissen, Mike Wenzel, et al.
Pageof 29